Jena, Germany

Volker H O Eckelt


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Volker H O Eckelt: Innovator in Biomolecular Screening Technology

Introduction

Volker H O Eckelt is a prominent inventor based in Jena, Germany. He has made significant contributions to the field of biomolecular screening, particularly in the development of innovative systems that enhance drug discovery processes. His work is characterized by a focus on label-free high throughput screening methods that are essential for modern pharmaceutical research.

Latest Patents

Eckelt holds a patent for a "Label-free high throughput biomolecular screening system and method." This patent describes a unique and practical solution for enabling label-free high throughput screening (HTS) to aid in the discovery of new drugs. The screening system allows for direct binding assays, enabling the detection of biomolecular interactions between drug candidates and therapeutic targets. It utilizes assay volumes and concentrations that align with current HTS practices in the pharmaceutical industry. The system also incorporates biosensors and surface chemistry to immobilize therapeutic targets, facilitating the detection of biochemical interactions within microplate wells. Additionally, it includes fluid handling and plate handling devices to automate HTS assays.

Career Highlights

Eckelt is associated with Corning Incorporated, a company known for its innovative solutions in materials science and life sciences. His work at Corning has been instrumental in advancing the capabilities of biomolecular screening technologies.

Collaborations

Eckelt has collaborated with notable colleagues such as Stephen Joseph Caracci and Anthony Glenn Frutos, contributing to the development of cutting-edge technologies in the field.

Conclusion

Volker H O Eckelt's contributions to biomolecular screening technology exemplify the innovative spirit of modern inventors. His patent for a label-free high throughput screening system represents a significant advancement in drug discovery methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…